Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA.

J Am Coll Cardiol. 2007 Apr 10;49(14):1505-16. Epub 2007 Mar 26. Review.

2.

Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.

Ben-Dor I, Kleiman NS, Lev E.

Am J Cardiol. 2009 Jul 15;104(2):227-33. doi: 10.1016/j.amjcard.2009.03.022. Epub 2009 May 13. Review.

PMID:
19576352
3.

Platelet reactivity and nonresponse to dual antiplatelet therapy: a review.

Vila PM, Zafar MU, Badimon JJ.

Platelets. 2009 Dec;20(8):531-8. doi: 10.3109/09537100903261379. Review.

PMID:
19845440
4.

Evaluation of clopidogrel responsiveness after drug-eluting stent implantation.

Price MJ.

Minerva Cardioangiol. 2009 Oct;57(5):657-66.

PMID:
19838155
5.

[Current options to manage clopidogrel poor responsiveness].

Fileti L, Campo G, Valgimigli M, Marchesini J, Ferrari R.

G Ital Cardiol (Rome). 2010 Dec;11(12):881-9. Review. Italian.

PMID:
21355335
6.

The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.

Bernlochner I, Byrne RA, Kastrati A, Sibbing D.

Expert Rev Cardiovasc Ther. 2011 Aug;9(8):999-1014. doi: 10.1586/erc.11.80. Review.

PMID:
21878045
7.

Significance of aspirin and clopidogrel resistance in patients undergoing percutaneous coronary interventions.

Pregowski J, Witkowski A, Sitkiewicz D.

Curr Vasc Pharmacol. 2007 Apr;5(2):135-40. Review.

PMID:
17430218
8.

Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.

Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):1-14. doi: 10.1002/ccd.21782. Review.

PMID:
19089929
9.

Clopidogrel and aspirin in cardiovascular medicine: responders or not--current best available evidence.

Tourmousoglou CE, Rokkas CK.

Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):312-22. Review.

PMID:
18855644
10.

Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.

Siller-Matula J, Schrör K, Wojta J, Huber K.

Thromb Haemost. 2007 Mar;97(3):385-93. Review.

PMID:
17334505
11.

Aspirin and clopidogrel: a sweeping combination in cardiology.

Manolis AS, Tzeis S, Andrikopoulos G, Koulouris S, Melita H.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Jul;3(3):203-19. Review.

PMID:
15974885
12.

Variability in responsiveness to oral antiplatelet therapy.

Angiolillo DJ.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):27A-34A. doi: 10.1016/j.amjcard.2008.11.020. Review.

PMID:
19166710
13.

Platelet monitoring for PCI: is it really necessary?

Tantry US, Gurbel PA.

Hamostaseologie. 2009 Nov;29(4):368-75. Review.

PMID:
19882080
15.

Latest clinical data on testing for high on-treatment platelet reactivity.

Fileti L, Campo G, Valgimigli M.

Rev Cardiovasc Med. 2011;12 Suppl 1:S14-22. Review.

PMID:
22080983
16.

Drug insight: Clopidogrel nonresponsiveness.

Gurbel PA, Tantry US.

Nat Clin Pract Cardiovasc Med. 2006 Jul;3(7):387-95. Review.

PMID:
16810174
17.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Motovska Z, Kala P.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Review.

PMID:
19281914
18.
19.

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Perneby C, Wallén NH, Hofman-Bang C, Tornvall P, Ivert T, Li N, Hjemdahl P.

Thromb Haemost. 2007 Dec;98(6):1316-22.

PMID:
18064330
20.

Clopidogrel resistance?

Gurbel PA, Tantry US.

Thromb Res. 2007;120(3):311-21. Epub 2006 Nov 14. Review.

PMID:
17109936

Supplemental Content

Support Center